UPDATE: FDA panel approves Ocular Therapeutix’ ReSeal, with reservations

FDA panel approves Ocular Therapeutix' ReSeal, with reservations

An FDA advisory panel voted yesterday that Ocular Therapeutix’s ReSure topical hydrogel post-op sealant is safe, but split on questions of efficacy and whether the benefits of the treatment outweigh its risks.

The FDA’s Ophthalmic Devices Panel voted 9-1, with 1 abstention, that the ReSure sealant is safe; 5-3, with 3 abstentions, that it is effective; and 5-1, with 5 abstentions, that its benefits outweigh its risks.

Ocular Therapeutix filed for PMA approval in February, based on a 488-patient clinical trial. The sealant’s proposed indication is for temporary sealing of clear corneal incisions to prevent leakage of fluid after cataract or intraocular lens placement surgery. While the FDA is not bound by the recommendations of its advisory panels, the agency often follows their advice.

Some panelists said they were unable to adequately assess the benefits vs. the risks of ReSure or whether it proved superiority over suture, given the conduct of the study, which included 370 protocol deviations.

Several panelists during the Gaithersburg, Md., meeting said that some word-smithing to the product’s proposed labelling would have changed their "no" votes on effectiveness to "yes."

Labeling is important "so that surgeons don’t imagine this is the same as a stitch," panelist Dr. Jayne Weiss of LSU Health Science Center in New Orleans said.

"The labeling is controlled by FDA and typically negotiated between the company and FDA," Ocular Therapeutix president & CEO Amar Sawhney told MassDevice.com. "So it will undergo some minor modifications, in all likelihood, but I cannot say what they will be."

Weiss also noted that Ocular Therapeutix conducted a 7-day study, rather than a 1- or 2-month study.

"I’m disturbed by it, because it doesn’t last very long and it doesn’t do very much," Weiss said. "It lasts less than 3 days, [but] that might be enough."

"You do not want to give the impression that this assures a healed wound," added Dr. Alice Matoba of Baylor College of Medicine in Houston. "It assures intact epithelium within a few days of the surgery, and that probably is helpful.

"But in no way does it keep the wound from leaking if there’s additional minor trauma, so I’m concerned that patients and clinicians may be lulled into a false feeling of security that they apply it and it’s done," Matoba said. "It only promotes epithelial healing and that has limited effectiveness, so how you define effectiveness would alter my answer to the question."

ReSure’s proposed Indication for Use is: "For intraoperative management of clear corneal incisions with a wound leak demonstrated by a Seidel test, and for prevention of postoperative fluid egress following cataract or intraocular lens placement surgery," according to the FDA. There are no devices approved in the U.S. for such an indication, the watchdog agency said ahead of the meeting.

The word "and" in the current IFU implies a prophylactic use for ReSure, and possibly 2 different uses for the sealant, according to panelists, which was not intended by the sponsor. This should be corrected, they advised the FDA.

The product’s proposed IFU also does not specify incision architecture or maximum length, the FDA pointed out. Panelists said a maximum incision width less than or equal to 3.5 mm should be identified as a prerequisite for use of ReSure.

The panel was split on whether incision architecture needed to be specified, but a strong argument was made in favor of leaving this to the surgeon’s discretion.

Panelists affirmed the need for a post-approval study and suggested some modifications to the proposed safety endpoints, including adding an assessment of wound leak, eliminating posterior vitreous detachment and getting "creative" with the assessment of endophthalmitis.

RSS From Medical Design & Outsourcing

  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]
  • Continuous 225W with natural convection for medical type BF power supply
    Powerbox, a European power supply company, introduces new Medline 225 series ac and dc single output open frame converters for medical type BF applications. The new OFM225 with its 3 x 5 in. footprint and 1.5 in. height is designed for a continuous output power of 225W with natural convection and 40°C ambient temperature, increasing to […]
  • Using data science to achieve ultra-low dose CT image reconstruction
    Prof. Jeff Fessler and Prof. Yong Long, Ph.D. of the University of Michigan-Shanghai Jiao Tong University (UM-SJTU) Joint Institute are collaborating on a project to develop a dramatically improved approach to low-dose X-ray CT image formation by extracting and using information from a big-data corpus of regular dose X-Ray Computed Tomography (CT) images. The research is […]

Leave a Reply